首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1370208

囊性纖維化治療市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Cystic Fibrosis Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年10月15日 | 出版商:

IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

市場概況：

2022年，全球囊性纖維化治療市場規模達到66億美元。展望未來，IMARC Group預計到2028年市場規模將達到112億美元，2023-2028年年複合成長率（CAGR）為9%。

囊性纖維化（CF）是一種罕見的進行性遺傳性疾病，其特徵是鈉和氯在胃腸道和呼吸道中的異常移動。這種疾病會導致肺部、胰臟、腸和肝臟產生黏稠分泌物。 CF的管理和治療包括物理治療、基因治療、物理治療和營養支持。除此之外，基因療法和藥物，例如胰酶補充劑、黏液溶解劑、支氣管擴張劑和囊性纖維化跨膜電導調節劑（CFTR）調節劑也用於靶向細胞相互作用組和症狀改善。這些藥物可以透過口服或吸入的方式給予患者。

全球囊性纖維化發生率的上升以及該疾病診斷技術的改進是推動市場成長的關鍵因素之一。此外，囊性纖維化跨膜電導（CFTR）調節劑作為治療替代品的廣泛採用也促進了市場成長。 CFTR 的作用是調節水和氯離子通過肺部和其他器官細胞壁的流動，並糾正體內故障的蛋白質。此外，各種技術進步，例如個人化藥物治療、分子假體和療效提高的創新藥物的開發，也是另一個生長誘導因素。其他因素，包括醫療保健支出的增加、健康意識的增強以及對囊性纖維化可用治療方案的認知，預計將進一步推動市場。

本報告回答的關鍵問題：

迄今為止，全球囊性纖維化治療市場的表現如何，未來幾年將如何表現？
主要區域市場有哪些？
COVID-19 對全球囊性纖維化治療市場有何影響？
根據藥物類別分類的市場是怎麼樣的？
根據藥物分子類型的市場細分是什麼？
根據給藥途徑，市場的分化為何？
基於最終用戶的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球囊性纖維化治療市場的結構是什麼？誰是主要參與者？
產業競爭程度如何？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太地區
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Abbvie Inc.
- Alaxia
- Alcresta Therapeutics Inc.
- Allergan
- AstraZeneca
- F. Hoffmann-La Roche Ltd
- Gilead Sciences Inc.
- Merck & Co., Inc.
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Vertex Pharmaceuticals Inc.

簡介目錄圖表

Product Code: SR112023A2117

Abstract

Market Overview:

The global cystic fibrosis therapeutics market size reached US$ 6.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2028, exhibiting a growth rate (CAGR) of 9% during 2023-2028.

Cystic fibrosis (CF) is a rare and progressive genetic disorder that is characterized by an abnormal movement of sodium and chloride across the gastrointestinal and respiratory tracts. This disorder can cause the development of viscous secretions in the lungs, pancreas, intestines and liver. The management and treatment of CF involve physical therapy, gene therapy, physiotherapy and nutritional support. Along with this, gene therapy and medicinal drugs, such as pancreatic enzyme supplements, mucolytics, bronchodilators and cystic fibrosis transmembrane conductance regulator (CFTR) modulators are also used for targeting cellular interactomes and symptomatic improvement. These drugs can be administered to the patient orally or by inhalation.

The rising incidence of cystic fibrosis across the globe, along with improvements in the diagnostic technologies of the disorder, is one of the key factors driving the growth of the market. Furthermore, widespread adoption of cystic fibrosis transmembrane conductance (CFTR) modulators as a treatment alternative is also providing a boost to the market growth. CFTRs are configured to regulate the flow of water and chloride through cell linings of the lungs and other organs and correct the malfunctioning protein in the body. Additionally, various technological advancements, such as the development of personalized drug therapy, molecular prosthetics and innovative drugs with improved efficacy, are acting as another growth-inducing factor. Other factors, including rising healthcare expenditures, increasing health consciousness, and awareness regarding the available treatment options for cystic fibrosis, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cystic fibrosis therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug class, drug molecule type, route of administration and end-user.

Breakup by Drug Class:

Pancreatic Enzyme Supplements

Mucolytics

Bronchodilators

CFTR Modulators

Antibiotics

Others

Breakup by Drug Molecule Type:

Small Molecule Drugs

Biologics

Breakup by Route of Administration:

Oral Drugs

Inhaled Drugs

Breakup by End-User:

Hospitals

Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being AbbVie Inc., Alaxia, Alcresta Therapeutics Inc., Allergan, AstraZeneca, F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Inc., etc.

Key Questions Answered in This Report:

How has the global cystic fibrosis therapeutics market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global cystic fibrosis therapeutics market?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the drug molecule type?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global cystic fibrosis therapeutics market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Cystic Fibrosis Therapeutics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Drug Class

6.1 Pancreatic Enzyme Supplements
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Mucolytics
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Bronchodilators
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 CFTR Modulators
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Antibiotics
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
6.6 Others
- 6.6.1 Market Trends
- 6.6.2 Market Forecast

7 Market Breakup by Drug Molecule Type

7.1 Small Molecule Drugs
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Biologics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Route of Administration

8.1 Oral Drugs
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Inhaled Drugs
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by End-User

9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abbvie Inc.
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Alaxia
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Alcresta Therapeutics Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Allergan
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 AstraZeneca
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 F. Hoffmann-La Roche Ltd
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 Gilead Sciences Inc.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Merck & Co., Inc.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Novartis AG
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Teva Pharmaceutical Industries Ltd.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Vertex Pharmaceuticals Inc.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Cystic Fibrosis Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Cystic Fibrosis Therapeutics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cystic Fibrosis Therapeutics Market: Breakup by Drug Class (in %), 2022
Figure 4: Global: Cystic Fibrosis Therapeutics Market: Breakup by Drug Molecule Type (in %), 2022
Figure 5: Global: Cystic Fibrosis Therapeutics Market: Breakup by Route of Administration (in %), 2022
Figure 6: Global: Cystic Fibrosis Therapeutics Market: Breakup by End-User (in %), 2022
Figure 7: Global: Cystic Fibrosis Therapeutics Market: Breakup by Region (in %), 2022
Figure 8: Global: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Cystic Fibrosis Therapeutics (Pancreatic Enzyme Supplements) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Cystic Fibrosis Therapeutics (Pancreatic Enzyme Supplements) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Cystic Fibrosis Therapeutics (Mucolytics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Cystic Fibrosis Therapeutics (Mucolytics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Cystic Fibrosis Therapeutics (Bronchodilators) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Cystic Fibrosis Therapeutics (Bronchodilators) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Cystic Fibrosis Therapeutics (CFTR Modulators) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Cystic Fibrosis Therapeutics (CFTR Modulators) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Cystic Fibrosis Therapeutics (Antibiotics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Cystic Fibrosis Therapeutics (Antibiotics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Cystic Fibrosis Therapeutics (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Cystic Fibrosis Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Cystic Fibrosis Therapeutics (Small Molecule Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Cystic Fibrosis Therapeutics (Small Molecule Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Cystic Fibrosis Therapeutics (Biologics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Cystic Fibrosis Therapeutics (Biologics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Cystic Fibrosis Therapeutics (Oral Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Cystic Fibrosis Therapeutics (Oral Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Cystic Fibrosis Therapeutics (Inhaled Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Cystic Fibrosis Therapeutics (Inhaled Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Cystic Fibrosis Therapeutics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Cystic Fibrosis Therapeutics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Cystic Fibrosis Therapeutics (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Cystic Fibrosis Therapeutics (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Cystic Fibrosis Therapeutics (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Cystic Fibrosis Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: North America: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: North America: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: United States: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: United States: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Canada: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Canada: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Asia Pacific: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Asia Pacific: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: China: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: China: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Japan: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Japan: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: India: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: India: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: South Korea: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: South Korea: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Australia: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Australia: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Indonesia: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Indonesia: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Others: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Others: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Europe: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Europe: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Germany: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Germany: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: France: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: France: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: United Kingdom: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: United Kingdom: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Italy: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Italy: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Spain: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Spain: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Russia: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Russia: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Others: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Others: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Latin America: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Latin America: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Brazil: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Brazil: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Mexico: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Mexico: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Middle East and Africa: Cystic Fibrosis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Middle East and Africa: Cystic Fibrosis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Global: Cystic Fibrosis Therapeutics Industry: SWOT Analysis
Figure 84: Global: Cystic Fibrosis Therapeutics Industry: Value Chain Analysis
Figure 85: Global: Cystic Fibrosis Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cystic Fibrosis Therapeutics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cystic Fibrosis Therapeutics Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
Table 3: Global: Cystic Fibrosis Therapeutics Market Forecast: Breakup by Drug Molecule Type (in Million US$), 2023-2028
Table 4: Global: Cystic Fibrosis Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 5: Global: Cystic Fibrosis Therapeutics Market Forecast: Breakup by End-User (in Million US$), 2023-2028
Table 6: Global: Cystic Fibrosis Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Cystic Fibrosis Therapeutics Market Structure
Table 8: Global: Cystic Fibrosis Therapeutics Market: Key Players

02-2729-4219

+886-2-2729-4219